Erica Finolezzi

Erica Finolezzi

UNVERIFIED PROFILE

Are you Erica Finolezzi?   Register this Author

Register author
Erica Finolezzi

Erica Finolezzi

Publications by authors named "Erica Finolezzi"

Are you Erica Finolezzi?   Register this Author

17Publications

320Reads

40Profile Views

Combination of rituximab and nonpegylated liposomal doxorubicin (R-NPLD) as front-line therapy for aggressive non-Hodgkin lymphoma (NHL) in patients 80 years of age or older: a single-center retrospective study.

Hematol Oncol 2018 Feb 3;36(1):44-48. Epub 2017 Feb 3.

Center for the Diagnosis and Treatment of Lymphomas, Department of Hematology, Transfusion Medicine and Biotechnology, Spirito Santo Hospital, Pescara, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.2386DOI Listing
February 2018

[18F]fluorodeoxyglucose positron emission tomography predicts survival after chemoimmunotherapy for primary mediastinal large B-cell lymphoma: results of the International Extranodal Lymphoma Study Group IELSG-26 Study.

J Clin Oncol 2014 Jun 5;32(17):1769-75. Epub 2014 May 5.

Maurizio Martelli and Erica Finolezzi, Sapienza University, Rome; Pier Luigi Zinzani and Stefano A. Pileri, Policlinico S. Orsola-Malpighi, Bologna; Andrés J.M. Ferreri, San Raffaele Scientific Institute, Milan; Umberto Vitolo, Azienda Ospedaliera S. Giovanni Battista, Torino; Caterina Stelitano, Azienda Ospedaliera Bianchi-Melacrino-Morelli, Reggio Calabria; Ercole Brusamolino, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo, Pavia; Maria Giuseppina Cabras, Ospedale Businco, Cagliari; Luigi Rigacci, Policlinico Careggi, Florence; Monica Balzarotti, IRCCS Humanitas, Rozzano; Flavia Salvi, Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo, Alessandria, Italy; Luca Ceriani, Emanuele Zucca, Franco Cavalli, and Luca Giovanella, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Silvia Montoto, Barts Cancer Institute, London; Andrew Davies and Peter W.M. Johnson, University of Southampton, Southampton, United Kingdom; and Armando Lopez-Guillermo, Hospital Clinic, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.51.7524DOI Listing
June 2014

Invasive Candida infections in patients with haematological malignancies and hematopoietic stem cell transplant recipients: current epidemiology and therapeutic options.

Mediterr J Hematol Infect Dis 2011 15;3(1):e2011013. Epub 2011 Mar 15.

Dipartimento di Ematologia, Oncologia, Anatomia Patologica e Medicina Rigenerativa, Azienda Policlinico Umberto I, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4084/MJHID.2011.013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3103241PMC
July 2011

Rituximab associated to imatinib for coexisting therapy-related chronic myeloid leukaemia and relapsed non-Hodgkin lymphoma.

Leuk Res 2008 Feb 7;32(2):353-5. Epub 2007 Sep 7.

Department of Cellular Biotechnology and Hematology, University La Sapienza, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2007.07.023DOI Listing
February 2008

Relevance of CD79a expression for T-cell lineage attribution in CD7+/CD3- acute lymphoblastic leukemia.

Haematologica 2002 Oct;87(10):ELT41

Dipartimento di Biotecnologie Cellulari ed Ematologia, Sezione di Ematologia, University La Sapienza, Rome, Italy.

View Article

Download full-text PDF

Source
October 2002